The “Cardiovascular-Kidney-Metabolic” Era in CKD Management: Integrated Risk Factor Control and Prognostic Benefits
American Journal of Nephrology · 29.04.2026 · 1-11
DOI: 10.1159/000552163 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Nephrology, online erschienen am 29.04.2026. Verfasst von Zhiqiang Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Introduction
The association between integrated management of metabolic risk factors, as proposed by the cardiovascular-kidney-metabolic syndrome concept, and cardiorenal outcomes in chronic kidney disease (CKD) patients is unclear; therefore, this study aimed to quantify this association, with a focus on specific risk factor combinations.
Methods
This retrospective cohort study included 42,763 patients with CKD from the China Renal Data System (CRDS). The degree of joint risk factor management was assessed based on 4 metabolic risk factors, namely, blood pressure, glucose, low-density lipoprotein cholesterol, and body mass index (BMI). The association between cardiorenal outcomes and the degree of risk factor control or specific risk combinations was assessed using Cox proportional hazards models up to 64,699.25 person-years of follow-up.
Results
In CKD patients, the degree of risk factor management demonstrated a dose-dependent association with lower risks of cardiovascular disease (CVD) events and CKD progression. Patients achieving management of all risk factors had significantly reduced HRs for CVD (0.69; 95% CI: 0.61–0.79) and CKD progression (0.79; 95% CI: 0.69–0.89) versus those with no management. The most protective combinations were blood pressure, glucose, and BMI management for CVD events (HR: 0.66; 95% CI: 0.57–0.77) and CKD progression (HR: 0.78; 95% CI: 0.69–0.89).
Conclusions
In this large CKD cohort, achieving simultaneous control of blood pressure, glucose, and BMI was associated with the greatest reduction in both cardiovascular and kidney outcomes, supporting integrated multi-target management within the CKM syndrome framework.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- National Clinical Research Center for Kidney and Urological Diseases, Nanfang Hospital, Guangzhou, China.
- State Key Laboratory of Multi-organ Injury Prevention and Treatment, Southern Medical University, Guangzhou, China.
- Guangdong Provincial Key Laboratory of Renal Failure Research, Guangdong Provincial Institute of Nephrology, Guangzhou, China.
- Nephrology Department, Ganzhou People's Hospital, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, China.
- Digital Health China Technologies, Beijing, China.
Zitieren
APA
Peng, Z., Liang, X., Su, L., You, Z., Zhu, L., Yang, Y., Wang, Y., Liu, D., & Liang, M. (2026). The “Cardiovascular-Kidney-Metabolic” Era in CKD Management: Integrated Risk Factor Control and Prognostic Benefits. American Journal of Nephrology, 1-11. https://doi.org/10.1159/000552163
Vancouver
Peng Z, Liang X, Su L, You Z, Zhu L, Yang Y, et al. The “Cardiovascular-Kidney-Metabolic” Era in CKD Management: Integrated Risk Factor Control and Prognostic Benefits. American Journal of Nephrology. 2026:1-11. doi:10.1159/000552163
BibTeX
@article{Peng2026,
author = {Peng, Zhiqiang and Liang, Xiaowei and Su, Licong and You, Ziyang and Zhu, Liheng and Yang, Yaya and Wang, Yu and Liu, Dehui and Liang, Min},
title = {The “Cardiovascular-Kidney-Metabolic” Era in CKD Management: Integrated Risk Factor Control and Prognostic Benefits},
journal = {American Journal of Nephrology},
year = {2026},
pages = {1--11},
doi = {10.1159/000552163}
}
EUVIMED